MedTrace Logo

Meaning of Life in HIV-infected Youths

NCT01644383 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2016-08-18

No results posted yet for this study

Summary

Logotherapy has never been evaluated in HIV-infected teenagers. In this study, we will evaluate the meaning of life by using The Purpose in Life Test and the affect of logotherapy in HIV infected youth at HIV-NAT, Thai Red Cross AIDS Research Centre and King Chulalongkorn Memorial Hospital.

Conditions

  • Meaning of Life

Interventions

BEHAVIORAL

logotherapy

Logotherapy is therapy during which the interaction between the therapist and the client centres on the topic of meaning. The problems that the clients experience are presented to the client as inseparable parts of his everyday life. The client is then challenged to discover his/her meaning and to take responsibility in facing up to his/her problem. This approach is aimed at helping the client to deal and understand what his /her existences entail.

Sponsors & Collaborators

  • Chulalongkorn University

    collaborator OTHER

  • Pediatric department, Chulalongkorn University, Bangkok, Thailand

    collaborator UNKNOWN

  • SEARCH Research Foundation

    collaborator OTHER

  • Wayne State University

    collaborator OTHER

  • University of Minnesota

    collaborator OTHER

  • The HIV Netherlands Australia Thailand Research Collaboration

    lead OTHER

Principal Investigators

  • Arunya Tuicomepee, PhD · Chulalongkorn University

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
24 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01644383 on ClinicalTrials.gov